MEGAN DESELMS: Open Payments
NPI 1225348972 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 60 payments from 13 companies in 2025. Trend: 2023 $680 · 2024 $1,306 · 2025 $1,513
Food & beverage: $1,499Education: $14
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $323 |
| Arcutis Biotherapeutics, Inc. | 10 | $228 |
| ABBVIE INC. | 12 | $226 |
| Janssen Biotech, Inc. | 9 | $225 |
| Lilly USA, LLC | 3 | $87 |
| PFIZER INC. | 3 | $72 |
| Incyte Corporation | 3 | $69 |
| GENZYME CORPORATION | 2 | $65 |
| Biofrontera Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
Products named: DUPIXENT, Zoryve, TREMFYA, SKYRIZI, RINVOQ, CIBINQO, OPZELURA, TALTZ.
Industry payments across FL — which companies pay providers there.
